Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 7/2011

01-07-2011 | Letter to the Editor

An unusual effect of colchicine treatment in Familial Mediterranean Fever-associated glomerulonephritis

Authors: Mevlut Ceri, Selman Unverdi, Mustafa Altay, Rahmi Yılmaz, Murat Duranay

Published in: Rheumatology International | Issue 7/2011

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Akpolat T, Akpolat I, Karagoz F, Yilmaz E, Kandemir B, Ozen S (2004) Familial Mediterranean fever and glomerulonephritis and review of the literature. Rheumatol Int 24:43–45PubMedCrossRef
2.
3.
Fonnesu C, Cerquaglia C, Giovinale M, Curigliano V, Verrecchia E, de Socio G, La Regina M, Gasbarrini G, Manna R (2009) Familial Mediterranean Fever: a review for clinical management. Joint Bone Spine 76:227–233PubMedCrossRef
4.
Cagdas DN, Gucer S, Kale G, Duzova A, Ozen S (2005) Familial Mediterranean fever and mesangial proliferative glomerulonephritis: report of a case and review of the literature. Pediatr Nephrol 20:1352–1354PubMedCrossRef
5.
Gok F, Sari E, Erdogan O, Altun D, Babacan O (2008) Familial Mediterranean Fever and IgA nephropaty: case report and review of the literature. Clin Nephrol 70:62–64PubMed
6.
Koukoui L, Blau A, Kopolovic J, Pras M, Livneh A (2004) A possible favorable effect of colchicine in IgA nephropathy in a carrier of a MEFV mutation. Clin Nephrol 62:226–228PubMed
Metadata
Title
An unusual effect of colchicine treatment in Familial Mediterranean Fever-associated glomerulonephritis
Authors
Mevlut Ceri
Selman Unverdi
Mustafa Altay
Rahmi Yılmaz
Murat Duranay
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1498-y

Other articles of this Issue 7/2011

Rheumatology International 7/2011 Go to the issue

Case Report

Pulmonary and psoas muscle nocardiosis in a patient with lupus nephritis: a case report and review of the literature

Original Article

The rehabilitation of facial involvement in systemic sclerosis: efficacy of the combination of connective tissue massage, Kabat’s technique and kinesitherapy: a randomized controlled trial

Letter to the Editor

Autoinflammatory disorders and patients with isolated serosal involvement

Case Report

Necrotizing fasciitis in a patient with overlap syndrome of systemic sclerosis and systemic lupus erythematosus

Original Article

Sexual functions in ankylosing spondylitis

Short Communication

Symptomatic noncompressive motoromyelopathy presents as early manifestation in ankylosing spondylitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits